A new asthma drug named Lunsekimig could be the answer for millions who remain dependent on inhalers. Here is what the phase ...
GoodRx reports that choosing the right asthma inhaler depends on symptom severity and frequency, with options for quick ...
The first one was that several participants did not know the correct inhaler regimen that they were actively prescribed at ...
Avalyn Pharma (AVLN) stock will be in focus as the company files for a Nasdaq IPO to fund clinical studies for its inhaled ...
Story County adds 2 drug drop boxes for unwanted medications ...
A new asthma drug, Lunsekimig, is showing promise in reducing inhaler dependence. Early trials report fewer symptoms, ...
A new study published in the Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation shows how an innovative phone-based inhaler education program helped Medicare Advantage ...
Avalyn Pharma is eyeing an IPO as the biotech seeks more funds to take its inhaled versions of approved drugs for lung ...
The ability of Ebenbuild GmbH’s digital twin technology to predict the deposition of inhaled drugs across the lungs has been ...
It’s been a little over two months since President Donald Trump’s direct-to-consumer pharmaceutical site, TrumpRx, launched, ...
NTU Singapore is working with China's Southern University of Science and Technology (SUSTech) and Swedish biotechnology ...
Inhaling marijuana via smoking or vaping is associated with a significantly greater risk for asthma attacks among young adults in the US.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results